Fingerprint
Dive into the research topics of 'Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically